METADICHOL
LIVE

Serial Number

87017926

Owner

NANORX INC.

Attorney

Scott D. Locke

First Use Date

Jun 10, 2010

Filing Date

Apr 28, 2016

Add to watchlist:

No watchlists yet
View on USPTO

METADICHOL Trademark

Serial Number: 87017926 • Registration: 5104308

METADICHOL is a trademark filed by NANORX INC. on April 28, 2016. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NANORX INC. (6 trademarks)

6 Devoe Place
Chappaqua, NY 10514

Entity Type: 03

Trademark Details

Filing Date

April 28, 2016

Registration Date

December 20, 2016

First Use Anywhere

June 10, 2010

First Use in Commerce

June 10, 2010

Published for Opposition

October 4, 2016

Goods & Services

Analgesic and muscle relaxant nutraceutical preparations; Anti-diabetic nutraceuticals; Cardiovascular nutraceuticals; Nutraceutical preparations for the treatment of gout; Nutraceutical preparations and substances for the treatment of gastro-intestinal diseases; Nutraceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Nutraceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Nutraceutical preparations for inhalation for the treatment of pulmonary hypertension; Nutraceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; Nutraceutical preparations for the treatment of inflammatory disorders; Nutraceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Nutraceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Nutraceutical preparations for the prevention of diabetes; Nutraceutical preparations for the treatment of eye diseases and conditions; Nutraceutical preparations for the treatment of heart rhythm disorders; Nutraceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Nutraceutical preparations for the treatment of infectious diseases; Nutraceutical preparations for the treatment of hypertension; Nutraceutical preparations for treating allergic rhinitis and asthma; Nutraceutical preparations for treating diabetes; Nutraceutical preparations for treating skin disorders; Nutraceutical preparations for use in urology; Nutraceutical preparations, namely, a blood clotting aid and delivery system for use in human and veterinary medicine; Nutraceutical products for ophthalmological use; Nutraceutical products for the treatment of bone diseases; Nutraceutical products for the treatment of joint disease; Nutraceutical products for the treatment of viral and infectious diseases; Nutraceutical preparations for the treatment of cancer; Nutraceutical products for treating respiratory diseases and asthma; Nutraceutical solutions used in dialysis; Nutraceuticals, namely, lipid lowering agents; Plant extracts for medical, veterinary and nutraceutical purposes; Therapeutic nutraceuticals for the treatment of obesity

Filing History

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Dec 20, 2025 REM2
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
May 18, 2023 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
May 18, 2023 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
May 18, 2023 APRE
TEAS SECTION 8 & 15 RECEIVED
Nov 3, 2022 E815
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Dec 20, 2021 REM1
REGISTERED-PRINCIPAL REGISTER
Dec 20, 2016 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 4, 2016 NPUB
PUBLISHED FOR OPPOSITION
Oct 4, 2016 PUBO
ASSIGNED TO EXAMINER
Oct 4, 2016 DOCK
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 14, 2016 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Aug 30, 2016 PREV
ASSIGNED TO LIE
Aug 30, 2016 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 15, 2016 CNSA
EXAMINER'S AMENDMENT ENTERED
Aug 15, 2016 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 15, 2016 GNEN
EXAMINERS AMENDMENT E-MAILED
Aug 15, 2016 GNEA
EXAMINERS AMENDMENT -WRITTEN
Aug 15, 2016 CNEA
ASSIGNED TO EXAMINER
Aug 15, 2016 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 2, 2016 NWOS
NEW APPLICATION ENTERED
May 2, 2016 NWAP